SEC Filing Details

We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need.

SEC Filing Details

Document Details

Form
Filing Date
Aug 3, 2017
Document Date
Aug 3, 2017
Filing Group
Other
Company
Poseida Therapeutics, Inc.
Issuer
Poseida Therapeutics, Inc.